15 published brand profiles in this category. Cite the individual brand profile for brand-specific facts.
Arvinas - Arvinas develops medicines based on targeted protein degradation, with research across oncology and neurology. Its PROTAC platform is designed to use the body’s protein-disposal system to degrade and remove disease-causing proteins.
Bicycle Therapeutics - Bicycle has grown steadily and consistently to evolve its technology. Its early years were about the challenge of perfecting a totally new and unique technology, industrialising it and learning where to apply it. The next phase saw a focus on developing therapeutics, aiming to de
Black Diamond Therapeutics - Our MasterKey therapies are designed to address broad genetically defined patient populations, overcome resistance, minimize wild-type mediated toxicities, and be brain penetrant to treat CNS disease. Our efforts are focused on non-small cell lung cancer (NSCLC) and glioblastoma
Calithera Biosciences - Calithera Biosciences is an oncology biotech company headquartered in South San Francisco, CA, founded in 2010.
Clovis Oncology - Clovis Oncology is an oncology biotech company headquartered in Boulder, CO, founded in 2009.
Five Prime Therapeutics - Five Prime Therapeutics is an oncology biotech company headquartered in South San Francisco, CA, founded in 2001.
Forty Seven - Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.
ImmunoGen - ImmunoGen is an oncology biotech company headquartered in Waltham, MA, founded in 1981.
Iovance Biotherapeutics - Tumor infiltrating lymphocytes (TIL) are naturally occurring immune cells that fight cancer. TIL are on constant surveillance to recognize, attack and kill cancer cells. When cancer invades and prevails, the TIL are unable to perform their intended function.
Kadmon Holdings - Kadmon Holdings is an oncology biotech company headquartered in New York, NY, founded in 2010.
MacroGenics - MacroGenics is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary
Mersana Therapeutics - Discover how Day One Biopharmaceuticals is disrupting the status quo of traditional drug development to bring new medicines to children and adults with cancer.
Peloton Therapeutics - Peloton Therapeutics is an oncology biotech company headquartered in Dallas, TX, founded in 2010.
Turning Point Therapeutics - Turning Point Therapeutics is an oncology biotech company headquartered in San Diego, CA, founded in 2013.